Full Circle

Testosterone Therapy May Lower Prostate Cancer Incidence

Hypogonadal men who receive testosterone replacement therapy (TRT) may have a lower incidence of prostate cancer (PCa) than those not receiving TRT, according to study findings presented at the Sexual Medicine Society of North America 18th Annual Fall Scientific Meeting in San Antonio, Texas. In addition, PCa diagnosed in TRT recipients is less severe than PCa diagnosed in men unexposed to TRT.

I have believed this for a long time, it is nice to see good studies supporting my views.

The new findings add to those from previous studies showing a protective effect of TRT against PCa. Earlier this year, Stacy Loeb, MD, of New York University, and colleagues published the results of a case-control study in the Journal of Clinical Oncology (2017;35:1430-1436) showing that men who received TRT had a decreased risk of aggressive PCa.

IT IS UNFORTUNATE THAT MOST DOCS STILL ARE AFRAID TO USE TESTOSTERONE FEARING THEY WILL CAUSE PROSTATE CANCER